On the public citation graph
Saporin toxin‐conjugated monoclonal antibody targeting prostate‐specific membrane antigen has potent anticancer activity
0 signed · 86 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/pros.10117openalex-snapshot
Anti‐tumor effects of toxins targeted to the prostate specific membrane antigen
inferredcites →https://doi.org/10.1016/s0090-4295(02)01583-2openalex-snapshot
Chemotherapy for prostate cancer
inferredcites →https://doi.org/10.1016/s0094-0143(02)00179-9openalex-snapshot
Localized prostate cancer: radiation or surgery?
inferredcites →https://doi.org/10.1016/s1357-2725(01)00128-5openalex-snapshot
Bioactivities of ricin retained and its immunoreactivity to anti-ricin polyclonal antibodies alleviated through pegylation
inferredcites →https://doi.org/10.1021/mp060105uopenalex-snapshot
Targeted Delivery and Enhanced Cytotoxicity of Cetuximab−Saporin by Photochemical Internalization in EGFR-Positive Cancer Cells
inferredcites →https://doi.org/10.1038/nbt0492-405openalex-snapshot
Ribosome–Inactivating Proteins from Plants: Present Status and Future Prospects
inferredcites →https://doi.org/10.1038/nrc801openalex-snapshot
A history of prostate cancer treatment
inferredcites →https://doi.org/10.1038/sj.cgt.7700629openalex-snapshot
Regression of prostate cancer xenografts by a lentiviral vector specifically expressing diphtheria toxin A
inferredcites →https://doi.org/10.1056/nejmoa041318openalex-snapshot
Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer
inferredcites →https://doi.org/10.1073/pnas.0502101102openalex-snapshot
Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase
inferredcites →https://doi.org/10.1073/pnas.1735443100openalex-snapshot
The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy
inferredcites →https://doi.org/10.1097/01.ju.0000091655.77601.0copenalex-snapshot
Targeting Metastatic Prostate Cancer With Radiolabeled Monoclonal Antibody J591 to the Extracellular Domain of Prostate Specific Membrane Antigen
inferredcites →https://doi.org/10.1097/01.mjt.0000133582.68709.e3openalex-snapshot
Chemotherapy for Prostate Cancer
inferredcites →https://doi.org/10.1097/cji.0b013e318031b53bopenalex-snapshot
Targeting, Imaging, and Therapy Using a Humanized Antiprostate Stem Cell Antigen (PSCA) Antibody
inferredcites →https://doi.org/10.1146/annurev.immunol.14.1.49openalex-snapshot
Immunotoxins: An Update
inferredcites →https://doi.org/10.1158/0008-5472.can-04-1722openalex-snapshot
A Prostate-Specific Membrane Antigen-Targeted Monoclonal Antibody–Chemotherapeutic Conjugate Designed for the Treatment of Prostate Cancer
inferredcites →https://doi.org/10.1158/0008-5472.can-07-1657openalex-snapshot
Targeting CUB Domain-Containing Protein 1 with a Monoclonal Antibody Inhibits Metastasis in a Prostate Cancer Model
inferredcites →https://doi.org/10.1158/1078-0432.ccr-05-2107openalex-snapshot
Potent Antitumor Activity of an Auristatin-Conjugated, Fully Human Monoclonal Antibody to Prostate-Specific Membrane Antigen
inferredcites →https://doi.org/10.1200/jco.2005.05.160openalex-snapshot
Phase I Trial of 177 Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer
inferredcites →https://doi.org/10.1200/jco.2007.15.0532openalex-snapshot
Phase I Trial of the Prostate-Specific Membrane Antigen–Directed Immunoconjugate MLN2704 in Patients With Progressive Metastatic Castration-Resistant Prostate Cancer
inferredcites →https://doi.org/10.1208/aapsj080363openalex-snapshot
Immunotoxins for targeted cancer therapy
inferredcites →https://doi.org/10.1593/tlo.08124openalex-snapshot
Tomoregulin Internalization Confers Selective Cytotoxicity of Immunotoxins on Prostate Cancer Cells
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/9783527682423.ch14openalex-snapshot
Antibody‐Targeted Drugs: From Chemical Immunoconjugates to Recombinant Fusion Proteins
inferred← citeshttps://doi.org/10.1002/adhm.201200254openalex-snapshot
An Anti‐PSMA Bivalent Immunotoxin Exhibits Specificity and Efficacy for Prostate Cancer Imaging and Therapy
inferred← citeshttps://doi.org/10.1002/advs.201701036openalex-snapshot
Boosting Antitumor Drug Efficacy with Chemically Engineered Multidomain Proteins
inferred← citeshttps://doi.org/10.1002/mabi.201500417openalex-snapshot
A Supramolecular Approach toward Bioinspired PAMAM‐Dendronized Fusion Toxins
inferred← citeshttps://doi.org/10.1002/med.21508openalex-snapshot
Targeting prostate cancer: Prostate‐specific membrane antigen based diagnosis and therapy
inferred← citeshttps://doi.org/10.1002/pros.22663openalex-snapshot
Construction and In Vitro/In Vivo Targeting of PSMA-Targeted Nanoscale Microbubbles in Prostate Cancer
inferred← citeshttps://doi.org/10.1007/978-1-4614-5456-4_15openalex-snapshot
Anti-PSMA Antibody-Drug Conjugates and Immunotoxins
inferred← citeshttps://doi.org/10.1007/978-94-007-6214-5_10openalex-snapshot
Current Status and Biomedical Applications of Ribosome-Inactivating Proteins
inferred← citeshttps://doi.org/10.1007/s00262-016-1873-yopenalex-snapshot
The HB22.7–vcMMAE antibody–drug conjugate has efficacy against non-Hodgkin lymphoma mouse xenografts with minimal systemic toxicity
inferred← citeshttps://doi.org/10.1007/s00432-017-2472-9openalex-snapshot
Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer
inferred← citeshttps://doi.org/10.1007/s11051-011-0439-3openalex-snapshot
Multifunctional iron platinum stealth immunomicelles: targeted detection of human prostate cancer cells using both fluorescence and magnetic resonance imaging
inferred← citeshttps://doi.org/10.1007/s13204-021-01974-6openalex-snapshot
Cytotoxic potential of bioactive seed proteins from Mallotus philippensis against various cancer cell lines
inferred← citeshttps://doi.org/10.1016/j.actbio.2020.06.019openalex-snapshot
Enzyme-responsive polymeric micelles of cabazitaxel for prostate cancer targeted therapy
inferred← citeshttps://doi.org/10.1016/j.bbcan.2011.11.003openalex-snapshot
Progress of molecular targeted therapies for prostate cancers
inferred← citeshttps://doi.org/10.1016/j.bmcl.2024.129657openalex-snapshot
PSMA-targeted SMART molecules outfitted with SN38
inferred← citeshttps://doi.org/10.1016/j.bmcl.2024.129712openalex-snapshot
A PSMA-targeted doxorubicin small-molecule drug conjugate
inferred← citeshttps://doi.org/10.1016/j.drudis.2012.03.007openalex-snapshot
Ribosome-inactivating proteins: current status and biomedical applications
inferred← citeshttps://doi.org/10.1016/j.jconrel.2014.05.035openalex-snapshot
Prostate cancer relevant antigens and enzymes for targeted drug delivery
inferred← citeshttps://doi.org/10.1016/j.leukres.2012.09.010openalex-snapshot
Efficacy of a CD22-targeted antibody-saporin conjugate in a xenograft model of precursor-B cell acute lymphoblastic leukemia
inferred← citeshttps://doi.org/10.1016/j.tranon.2020.101007openalex-snapshot
Development of near-infrared imaging agents for detection of junction adhesion molecule-A protein
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.8b00741openalex-snapshot
Sequential Prodrug Strategy To Target and Eliminate ACPA-Selective Autoreactive B Cells
inferred← citeshttps://doi.org/10.1038/s41467-023-42480-3openalex-snapshot
Immune synapse formation promotes lipid peroxidation and MHC-I upregulation in licensed dendritic cells for efficient priming of CD8+ T cells
inferred← citeshttps://doi.org/10.1039/9781849733151-00062openalex-snapshot
Glutamate Carboxypeptidase II as a Therapeutic Target
inferred← citeshttps://doi.org/10.1039/c1sm05310hopenalex-snapshot
An in situ-forming, solid lipid/PLGA hybrid implant for long-acting antipsychotics
inferred← citeshttps://doi.org/10.1039/c8cs00590gopenalex-snapshot
Functional protein nanostructures: a chemical toolbox
inferred← citeshttps://doi.org/10.1039/d5ma00933bopenalex-snapshot
Novel approaches for detection and targeted therapy of prostate cancer using antibodies, aptamers, and nanobodies
inferred← citeshttps://doi.org/10.1073/pnas.1316026110openalex-snapshot
Bispecific small molecule–antibody conjugate targeting prostate cancer
inferred← citeshttps://doi.org/10.1073/pnas.1714587115openalex-snapshot
PSMA-targeted polyinosine/polycytosine vector induces prostate tumor regression and invokes an antitumor immune response in mice
inferred← citeshttps://doi.org/10.1089/hyb.2012.0048openalex-snapshot
Camel Heavy Chain Antibodies Against Prostate-Specific Membrane Antigen
inferred← citeshttps://doi.org/10.1158/1535-7163.mct-15-0722openalex-snapshot
Theranostic Agents for Photodynamic Therapy of Prostate Cancer by Targeting Prostate-Specific Membrane Antigen
inferred← citeshttps://doi.org/10.1158/1541-7786.mcr-16-0193openalex-snapshot
Induction of PSMA and Internalization of an Anti-PSMA mAb in the Vascular Compartment
inferred← citeshttps://doi.org/10.11606/t.76.2017.tde-11092017-083859openalex-snapshot
Endocitose e transporte intracelular de isoformas da pulchellina
inferred← citeshttps://doi.org/10.1186/s12934-024-02496-wopenalex-snapshot
Characterization of MAP c21873-1 as a new counter-selectable marker for unmarked genetic modification of Pichia pastoris
inferred← citeshttps://doi.org/10.1186/s40425-019-0741-7openalex-snapshot
CAR-T cell therapy: a potential new strategy against prostate cancer
inferred← citeshttps://doi.org/10.1186/s40880-015-0030-xopenalex-snapshot
Anti-tumor activities and apoptotic mechanism of ribosome-inactivating proteins
inferred← citeshttps://doi.org/10.1371/journal.pone.0015921openalex-snapshot
Rise and Fall of an Anti-MUC1 Specific Antibody
inferred← citeshttps://doi.org/10.1371/journal.pone.0033009openalex-snapshot
The Study on Newly Developed McAb NJ001 Specific to Non-Small Cell Lung Cancer and Its Biological Characteristics
inferred← citeshttps://doi.org/10.1371/journal.pone.0246197openalex-snapshot
Identification of Prostaglandin F2 Receptor Negative Regulator (PTGFRN) as an internalizable target in cancer cells for antibody-drug conjugate development
inferred← citeshttps://doi.org/10.14366/usg.16006openalex-snapshot
Theragnostic ultrasound using microbubbles in the treatment of prostate cancer
inferred← citeshttps://doi.org/10.1593/neo.13986openalex-snapshot
Combination of the PI3K Inhibitor ZSTK474 with a PSMA-Targeted Immunotoxin Accelerates Apoptosis and Regression of Prostate Cancer
inferred← citeshttps://doi.org/10.18869/acadpub.rmm.4.3.3openalex-snapshot
Targeted Cancer Diagnostic and Therapeutic Agents: Delivery by Carriers or Conjugation
inferred← citeshttps://doi.org/10.20517/jtgg.2023.50openalex-snapshot
New approaches and prospects of immunotherapy and gene therapy for prostate cancer
inferred← citeshttps://doi.org/10.2174/1381612820666140826153913openalex-snapshot
Immunotoxins Constructed with Ribosome-Inactivating Proteins and their Enhancers: A Lethal Cocktail with Tumor Specific Efficacy
inferred← citeshttps://doi.org/10.2174/156652409789839071openalex-snapshot
Ribosome Inactivating Proteins (RIPs) from Momordica charantia for Anti Viral Therapy
inferred← citeshttps://doi.org/10.2217/imt.11.5openalex-snapshot
Antibody-Targeted Nanoparticles for Cancer Therapy
inferred← citeshttps://doi.org/10.2306/scienceasia1513-1874.2020.086openalex-snapshot
An effective invasive therapeutic approach of fluoro-substituted zinc phthalocyanine derivatives as potential photosensitizer for prostate carcinoma
inferred← citeshttps://doi.org/10.2967/jnumed.117.196279openalex-snapshot
Characterization of Site-Specifically Conjugated Monomethyl Auristatin E– and Duocarmycin-Based Anti-PSMA Antibody–Drug Conjugates for Treatment of PSMA-Expressing Tumors
inferred← citeshttps://doi.org/10.32657/10356/72381openalex-snapshot
Characterisation and development of 2448 and C51 : novel monoclonal antibodies targeting ovarian and breast cancer
inferred← citeshttps://doi.org/10.3390/biomedicines9080986openalex-snapshot
Targeted Toxins for the Treatment of Prostate Cancer
inferred← citeshttps://doi.org/10.3390/cancers14225719openalex-snapshot
Current Developments in Cellular Therapy for Castration Resistant Prostate Cancer: A Systematic Review of Clinical Studies
inferred← citeshttps://doi.org/10.3390/cancers4010193openalex-snapshot
Tumor-Associated Antigens for Specific Immunotherapy of Prostate Cancer
inferred← citeshttps://doi.org/10.3390/ijms22020640openalex-snapshot
Chimeric Antigen Receptor-Engineered T Cell Therapy for the Management of Patients with Metastatic Prostate Cancer: A Comprehensive Review
inferred← citeshttps://doi.org/10.3390/toxins15030181openalex-snapshot
Streptavidin-Saporin: Converting Biotinylated Materials into Targeted Toxins
inferred← citeshttps://doi.org/10.3390/toxins2112699openalex-snapshot
Ribosome-Inactivating Proteins: From Plant Defense to Tumor Attack
inferred← citeshttps://doi.org/10.3390/toxins3060697openalex-snapshot
Immunotoxins and Other Conjugates Containing Saporin-S6 for Cancer Therapy
inferred← citeshttps://doi.org/10.3390/toxins5101698openalex-snapshot
Saporin-S6: A Useful Tool in Cancer Therapy
inferred← citeshttps://doi.org/10.3892/ijo.2019.4706openalex-snapshot
The proteasome inhibitor, bortezomib, induces prostate cancer cell death by suppressing the expression of prostate-specific membrane antigen, as well as androgen receptor
inferred← citeshttps://doi.org/10.4161/onci.21815openalex-snapshot
Efficacy and toxicity of a CD22-targeted antibody-saporin conjugate in a xenograft model of non-Hodgkin’s lymphoma
inferred← citeshttps://doi.org/10.5772/26951openalex-snapshot
Prostate Specific Membrane Antigen as Biomarker and Therapeutic Target for Prostate Cancer
inferred← citeshttps://doi.org/10.6092/unibo/amsdottorato/4707openalex-snapshot
Genetic engineering and preclinical evaluation of oncolytic herpes simplex viruses retargeted to cancer-specific receptors
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.